Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 607364, 7 pages
http://dx.doi.org/10.1155/2015/607364
Research Article

Association of Metabolic Syndrome with the Adiponectin to Homeostasis Model Assessment of Insulin Resistance Ratio

1Department of Nutrition and Food Hygiene, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2Department of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang 832000, China
3Department of Pathology and Key Laboratory of Xinjiang Endemic and Ethnic Diseases (Ministry of Education), Shihezi University School of Medicine, Shihezi, Xinjiang 832002, China

Received 24 July 2015; Accepted 20 September 2015

Academic Editor: Consolato M. Sergi

Copyright © 2015 Yu-Song Ding et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. H. Del Brutto, R. M. Mera, M. Montalván et al., “Cardiovascular health status and metabolic syndrome in Ecuadorian natives/mestizos aged 40 years or more with and without stroke and ischemic heart disease—an Atahualpa project case-control nested study,” Journal of Stroke & Cerebrovascular Diseases, vol. 23, no. 4, pp. 643–648, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. T. M. Ahonen, J. T. Saltevo, H. J. Kautiainen, E. A. Kumpusalo, and M. J. Vanhala, “The association of adiponectin and low-grade inflammation with the course of metabolic syndrome,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 22, no. 3, pp. 285–291, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. Grundy, “Metabolic syndrome pandemic,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 4, pp. 629–636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Kaur, “A comprehensive review on metabolic syndrome,” Cardiology Research and Practice, vol. 2014, Article ID 943162, 21 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Blaha, S. Bansal, R. Rouf, S. H. Golden, R. S. Blumenthal, and A. P. DeFilippis, “A practical “ABCDE” approach to the metabolic syndrome,” Mayo Clinic Proceedings, vol. 83, no. 8, pp. 932–943, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. P. M. Siu and Q. S. Yuen, “Supplementary use of HbA1c as hyperglycemic criterion to detect metabolic syndrome,” Diabetology & Metabolic Syndrome, vol. 6, article 119, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Sattar, A. McConnachie, A. G. Shaper et al., “Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies,” The Lancet, vol. 371, no. 9628, pp. 1927–1935, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Singh, S. Arora, B. Goswami, and V. Mallika, “Metabolic syndrome: a review of emerging markers and management,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 3, no. 4, pp. 240–254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Lee, H. B. Jang, M. Ra et al., “Prediction of future risk of insulin resistance and metabolic syndrome based on Korean boy's metabolite profiling,” Obesity Research & Clinical Practice, vol. 9, no. 4, pp. 336–345, 2015. View at Publisher · View at Google Scholar
  10. J.-H. Yoon, J. K. Park, S. S. Oh et al., “The ratio of serum leptin to adiponectin provides adjunctive information to the risk of metabolic syndrome beyond the homeostasis model assessment insulin resistance: the Korean Genomic Rural Cohort Study,” Clinica Chimica Acta, vol. 412, no. 23-24, pp. 2199–2205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Guo, “Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms,” The Journal of Endocrinology, vol. 220, no. 2, pp. T1–T23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Kimm, S. W. Lee, H. S. Lee et al., “Associations between lipid measures and metabolic syndrome, insulin resistance and adiponectin,” Circulation Journal, vol. 74, no. 5, pp. 931–937, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Haffner, E. Kennedy, C. Gonzalez, M. P. Stern, and H. Miettinen, “A prospective analysis of the homa model: the mexico city diabetes study,” Diabetes Care, vol. 19, no. 10, pp. 1138–1141, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Cao, T. Yang, S. Yu, G. Sun, C. Gu, and D. Yi, “Relationships of adiponectin with markers of systemic inflammation and insulin resistance in infants undergoing open cardiac surgery,” Mediators of Inflammation, vol. 2013, Article ID 187940, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Yadav, M. A. Kataria, V. Saini, and A. Yadav, “Role of leptin and adiponectin in insulin resistance,” Clinica Chimica Acta, vol. 417, pp. 80–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Ohashi, D. Yuasa, R. Shibata, T. Murohara, and N. Ouchi, “Adiponectin as a target in obesity-related inflammatory state,” Endocrine, Metabolic & Immune Disorders-Drug Targets, vol. 15, no. 2, pp. 145–150, 2015. View at Publisher · View at Google Scholar
  18. R. Timar, B. Timar, D. Degeratu, C. Serafinceanu, and C. Oancea, “Metabolic syndrome, adiponectin and proinflammatory status in patients with type 1 diabetes mellitus,” The Journal of International Medical Research, vol. 42, no. 5, pp. 1131–1138, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Herder, D. M. Ouwens, M. Carstensen et al., “Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 Study,” European Journal of Endocrinology, vol. 172, no. 4, pp. 423–432, 2015. View at Publisher · View at Google Scholar
  20. H. Chen, L. Zhang, X. Li et al., “Adiponectin activates the AMPK signaling pathway to regulate lipid metabolism in bovine hepatocytes,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 138, pp. 445–454, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S.-B. Koh, J. Yoon, J.-Y. Kim et al., “Relationships between serum adiponectin with metabolic syndrome and components of metabolic syndrome in non-diabetic Koreans: Arirang study,” Yonsei Medical Journal, vol. 52, no. 2, pp. 234–241, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-B. Koh, J.-K. Park, J.-H. Yoon et al., “Preliminary report: a serious link between adiponectin levels and metabolic syndrome in a Korean nondiabetic population,” Metabolism: Clinical and Experimental, vol. 59, no. 3, pp. 333–337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Nakatochi, S. Miyata, D. Tanimura et al., “The ratio of adiponectin to homeostasis model assessment of insulin resistance is a powerful index of each component of metabolic syndrome in an aged Japanese population: results from the KING Study,” Diabetes Research and Clinical Practice, vol. 92, no. 3, pp. e61–e65, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. K. G. M. M. Alberti, P. Zimmet, and J. Shaw, “The metabolic syndrome—a new worldwide definition,” The Lancet, vol. 366, no. 9491, pp. 1059–1062, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. Q. Zhuo, Z. Wang, P. Fu et al., “Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities,” Diabetes Research and Clinical Practice, vol. 84, no. 1, pp. 27–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. M. Grundy, J. I. Cleeman, S. R. Daniels et al., “Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement,” Current Opinion in Cardiology, vol. 21, no. 1, pp. 1–6, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. P. López-Jaramillo, D. Gómez-Arbeláez, J. López-López et al., “The role of leptin/adiponectin ratio in metabolic syndrome and diabetes,” Hormone Molecular Biology and Clinical Investigation, vol. 18, no. 1, pp. 37–45, 2014. View at Publisher · View at Google Scholar
  28. Y. Saisho, H. Hirose, R. Roberts, T. Abe, H. Kawabe, and H. Itoh, “C-reactive protein, high-molecular-weight adiponectin and development of metabolic syndrome in the Japanese general population: a longitudinal cohort study,” PLoS ONE, vol. 8, no. 9, Article ID e73430, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Eglit, M. Lember, I. Ringmets, and T. Rajasalu, “Gender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome,” European Journal of Endocrinology, vol. 168, no. 3, pp. 385–391, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Ding, S. Li, R. L. Ma et al., “Association of homeostasis model assessment of insulin resistance, adiponectin, and low-grade inflammation with the course of the metabolic syndrome,” Clinical Biochemistry, vol. 48, no. 7-8, pp. 503–507, 2015. View at Publisher · View at Google Scholar
  31. J. E. Yun, S. Won, Y. Mok, W. Cui, H. Kimm, and S. H. Jee, “Association of the leptin to high-molecular-weight adiponectin ratio with metabolic syndrome,” Endocrine Journal, vol. 58, no. 9, pp. 807–815, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Seino, H. Hirose, I. Saito, and H. Itoh, “High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men,” Metabolism: Clinical and Experimental, vol. 56, no. 11, pp. 1493–1499, 2007. View at Publisher · View at Google Scholar · View at Scopus